With $8 million in seed funding, Droplet is developing a test for minimal residual disease detection in head and neck cancer, with research ongoing for other promising targets.
At ACMG, GUARDIAN Newborn Sequencing Study Reports High Uptake Rate
The researchers have already identified babies with G6PD deficiency who would have been missed by standard newborn screening.
ACMG Statement Says Preimplantation Polygenic Risk Testing "Not Appropriate for Clinical Use" Yet
Overall, the organization remains skeptical of the clinical implementation of PRS testing, pointing to limitations of the tests and a lack of evidence for their clinical utility.
New NASEM Report Suggests Dropping Race, Ethnicity Tags From Genetic, Genomic Studies
In the report, an NASEM committee has compiled a list of recommendations for genetic researchers to ensure appropriate usage of population descriptors.
The new method from a KU Leuven team offers insights into clonal profiling with applications in minimal residual disease.